Skip to content
Open Menu
Search for:
News & events
Insight & resources
Facilities
Careers
Contact
Drug substance
Back to main menu
Drug substance
Custom development
Process development & validation
Analytical development & validation
Custom manufacturing
Technology transfer
Manufacturing capabilities
Quality & regulatory
Environment, health & safety
Generic APIs
Product catalogue
Controlled substances
High potency APIs
Specialist technologies
Biocatalysis
Continuous flow
Controlled substances
Crystallization process development
High potency APIs
Solid state science
Material characterization
Drug product
Back to main menu
Drug product
Custom development
Formulation development
Analytical development & validation
Clinical supply
Custom manufacturing
Technology transfer
Manufacturing capabilities
Quality & regulatory
Environment, health & safety
Packaging
Conventional dosage forms
Solid dose
Semi-solid dose
Liquids
Specialized dosage forms
Fixed-dose combinations
Pediatric
Bi-layer tablets
Stick packs
Topicals
Controlled substances
Sterile & non-sterile
Solid state science
Material characterization
Analytical services
Back to main menu
Analytical services
Compendial testing
Microbiology
Cleanroom services
Release & QC testing
Extractables/leachables studies
Stability storage
Method development & validation
Material characterization
Elemental impurities
Impurity isolation, identification & characterization
Reference standard qualification
Bioanalytical & biopharmaceutical analysis
Open Search
News & events
Search news
Post date
Post Date
Tags
Tags
All Tags
About (2)
analytical services (2)
APIs (5)
biocatalysis (1)
Cambrex (8)
Careers (1)
cGMP (1)
Chemical Molecules (1)
Chemistry (1)
CMO (1)
CMOs (1)
Company (2)
Compounds (1)
Continuous flow (2)
Corporate Brochure (1)
Custom Development (1)
Development (1)
Drug product (5)
Drug substance (9)
Facilities (2)
HPAPIs (1)
Information Sheets (1)
Literature (5)
Manufacturing (1)
Meet our experts (1)
Opioids (1)
Pharmaceutical (1)
Resources (5)
Small Molecule (2)
Video (1)
Webcasts (1)
Webinar (6)
By author
By Author
All Authors
Alex Maw (17)
Cambrex (99)
Hannah McLachlan (3)
Lisa Glendinning (1)
Nicola Good (2)
Advanced search
Latest news
Read more
November 17, 2020
Cambrex to Invest $50 Million to Expand Multipurpose Large-Scale Manufacturing Capabilities in the U.S.
October 12, 2020
Cambrex Completes Major Expansion of Solid Form Screening Facility in Edinburgh
July 1, 2020
Cambrex Increases Flexible Manufacturing Capacity at Karlskoga, Sweden Facility
June 18, 2020
Cambrex Names Thomas Loewald As Chief Executive Officer
June 2, 2020
Cambrex Announces Management Transitions
April 7, 2020
Cambrex Completes Biopharmaceutical Expansion at its Durham, NC Facility
March 31, 2020
Cambrex Appoints Troy Player as President, Early Stage Development & Testing Business Unit
Read more from our news archive
Skip to content Open Menu